Magic mushroom therapy tested for cancer Patients' emotional pain
NCT ID NCT06818994
Summary
This early-stage study is testing whether psilocybin (the active compound in 'magic mushrooms'), combined with therapy, can safely help reduce severe emotional distress in people with advanced cancer. Fifteen participants will receive therapy sessions and one dose of psilocybin to see if it lessens feelings of hopelessness and despair. The main goals are to check for safety and see if the treatment reduces demoralization, a specific type of psychological suffering common in serious illness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMORALIZATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Queen's University
RECRUITINGKingston, Ontario, K7L 3N6, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.